Navigation Links
Eloxatin in Medical News

Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

...eria . No patient in any dose group exhibited any signs of acute neurotoxicity, which is a major adverse side-effect of the approved DACH platinum, eloxatin , and ProLindac was well tolerated overall. The Company has scaled up manufacturing in order to begin the next phase of clinical development. Access ...

Sanofi-aventis Announces Good First-quarter 2009 Performance

...cation approved in the second half of 2008. In the United States, the product posted 2.9% growth in net sales to euro 197 million. Net sales of eloxatin (R) , the leading cytotoxic agent in the colorectal cancer market as an adjuvant and as first line treatment in the metastatic phase, were up 3.0% at...

Sanofi-aventis Delivers 2008 Results Above Guidance

...sed by 17.8% (to EUR 49 million) in the fourth quarter and by 14.9% (to EUR 142 million) over the full year. In the United States, net sales of eloxatin (R) , the leading cytotoxic agent in the colorectal cancer market as an adjuvant and in the metastatic phase, rose by 6.9% to EUR 265 million in the ...

Eloxatin combination reduces bowel cancer recurrences

...study involving patients taking supplementation of eloxatin drug with other chemotherapeutic cancer drug for t...s called as NICE study has proved a combination of eloxatin with chemotherapeutic drugs more effective than co...nic acid. The study has found combination of eloxatin with 5-Fluorouracil and Folinic acid more effectiv...
Eloxatin in Medical Technology

New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data

... noted Dr. de Gramont. "Inclusion of these survival results in the new U.S. eloxatin PI marks an important milestone in the treatment of colon cancer." About ...two weeks for 12 cycles. The primary endpoint evaluated how the addition of eloxatin affected disease-free survival at three years. Secondary endpoints included...

Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review

...r Stage III colon cancer patients." In the MOSAIC trial, Stage III colon cancer patients treated after complete surgical resection of the tumor with eloxatin in combination with infusional 5-FU/LV had a significant reduction (20%) in the risk of dying after a median of six years compared to standard 5FU/LV-...

Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research

...atment of patients with advanced carcinoma of the colon or rectum. In 2004, eloxatin received additional approval for the first-line treatment of these patients. Based on data showing improvement in disease-free survival, eloxatin was also approved in 2004 for use in combination with infusional 5-FU/LV in...

The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer

...s were resected; of these, 115 patients (63%) received post-operative chemotherapy. In the standard arm, 152 patients' liver metastases were resected. eloxatin is not approved for peri-operative use in the United States. About Colorectal Cancer Colorectal cancer is a leading cause of death. Every year, ab...
Eloxatin in Medical Dictionary

Injection

...se. Read more about the prescription drug OXALIPLATIN - INJECTION . ... home > oxaliplatin- injection index > oxaliplatin- injection , eloxatin drug monograph ... Consumer information about the medication FOLIC ACID - INJECTION (Folvite), includes side effects, drug interactions, rec...
Eloxatin in Biological Technology

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...in New York (NYSE: SNY ). For more information, visit: www.sanofi-aventis.us or www.sanofi-aventis.com . Please see the accompanying eloxatin (oxaliplatin injection), Lovenox (enoxaparin sodium injection), and Taxotere (docetaxel) Injection Concentrate full prescribing information, including...

Sanofi-aventis Announces Second Quarter 2009 Results

...h metastatic breast cancer, based on the results of the AVADO study. First-half net sales of Taxotere((R)) were up 9.5% at euro 1,118 million. eloxatin ((R)) , the leading cytotoxic agent in the colorectal cancer market as an adjuvant and as a first-line treatment in the metastatic phase, achieved se...

Hospira Receives Favorable Court Decision on Eloxatin(R)

...e generic name oxaliplatin injection, will be one of the first generic versions available in the United States to come in solution form. U.S. sales of eloxatin last year were approximately $1.4 billion. "We are extremely pleased with the court's ruling," said Joshua Gordon, vice president, Specialty Phar...

Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer

...). Results also continue to indicate that both regimens have similar anti-tumor activity in first-line metastatic CRC. Net sales in 2007 in the US for eloxatin (oxaliplatin) were approximately $1.3 billion. "These new data continue to suggest that picoplatin is an active platinum agent in colorectal canc...

Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL

...ug Application (ANDA) containing a paragraph IV certification for a generic eloxatin product with the U.S. Food & Drug Administration (FDA), and following FDA n...rmally initiates the patent challenge process under the Hatch-Waxman Act. eloxatin (Oxaliplatin Aqueous Solution), 5mg/mL Injectable, used in combination with...

Access Highlighted in Recent BusinessWeek Article

...rcial also noted that Dr. Esteban Cvitkovic, Access' Vice-Chairman (Europe) and Senior Director, Oncology Clinical R&D, was responsible for developing eloxatin during his tenure at Sanofi-Aventis. The article references certain products of Somanta Pharmaceuticals in the cancer area. While Access has executed ...
Other Tags
(Date:9/30/2014)... University of Maryland-led research team has been awarded ... Institutes of Health (NIH) to develop new imaging ... our understanding of how large networks of neurons ... This knowledge will help researchers identify the precise ... behavior, like decision-making and speaking, and alterations in ...
(Date:9/30/2014)... EverStryke , the permanent match currently offered ... with a free book and class all about survival education ... an investigative review. , “Joe Marshall of SurvivalLife.com is ... preparation niche, and this product is an excellent way to ... products that Joe offers on his website to help people ...
(Date:9/30/2014)... NV (PRWEB) September 30, 2014 Elevate ... helping people perform better in and out of the gym ... memory has caught the attention of Shane Michaels, prompting an ... grind, fatigue is the reason most people simply just don’t ... that means staying focused at work, getting the motivation to ...
(Date:9/30/2014)... September 30, 2014 VisitandCare.com ... Turkey has gone up more than 79 percent in ... tourism company also reported total revenue tripled for its ... The company’s professional strategy has allowed them to partner ... designed for patient comfort and privacy — with state-of-the-art ...
(Date:9/30/2014)... 30, 2014 Hospice & Palliative ... “In Celebration” gala, honoring three outstanding individuals for ... striving to provide extraordinary and dignified comfort, care ... serious or life-limiting illness. , The event was ... NY and recognized William (Bill) J. McGuinness, Director ...
Breaking Medicine News(10 mins):Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2
(Date:9/29/2014)... order to support the world,s needs to make ... more, new and more efficient catalytic materials and ... including several from Wayne State University, is tackling ... grant from the National Science Foundation. , The ... Multicomponent Materials for Electrocatalytic Cascade Reactions," was to ...
(Date:9/29/2014)... Scientists at Washington State University have concluded ... Smith apples may help prevent disorders associated ... first to assess these compounds in apple cultivars ... print edition of the journal Food Chemistry ... a good source of these nondigestible compounds but ...
(Date:9/29/2014)... presented Dr. Cristin Samper, president and CEO of ... of San Carlos. , The Order of San ... officers who have made outstanding contributions to the ... , An international authority on conservation biology and ... Colombian Residence in New York to receive the ...
Breaking Biology News(10 mins):Wayne State research aims to develop new, more efficient catalytic materials 2An apple a day could keep obesity away 2
Other Contents